Tauriga Sciences, Inc. Share Price Other OTC
Equities
TAUG
US87669X2053
Pharmaceuticals
Sales 2020 | 0.23 18.72 | Sales 2021 | 0.29 22.79 | Capitalization | 29.3M 2.34B |
---|---|---|---|---|---|
Net income 2020 | -3M -240M | Net income 2021 | -3M -240M | EV / Sales 2020 | 15,901,203 x |
Net Debt 2020 | 373K 29.83M | Net cash position 2021 | 1.04M 82.98M | EV / Sales 2021 | 99,058,952 x |
P/E ratio 2020 |
-0.87
x | P/E ratio 2021 |
-6.09
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 21/08/12 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 04/07/17 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 14/07/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 07/03/21 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 21/08/12 |
Director/Board Member | 46 | 07/03/21 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |